Cargando…
Pentosan polysulfate ameliorates fibrosis and inflammation markers in SV40 MES13 cells by suppressing activation of PI3K/AKT pathway via miR-446a-3p
BACKGROUND: Renal fibrosis is a common outcome of various renal damage, including diabetic nephropathy (DN), the leading cause of end-stage renal disease. Currently, there are no effective therapies for renal fibrosis. The present study aimed to determine whether pentosan polysulphate sodium (PPS),...
Autores principales: | Xiao, Liangxiang, Chen, Anqun, Gao, Qing, Xu, Bo, Guo, Xiaodan, Guan, Tianjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925175/ https://www.ncbi.nlm.nih.gov/pubmed/35291969 http://dx.doi.org/10.1186/s12882-022-02732-8 |
Ejemplares similares
-
Maculopathy caused by pentosan polysulfate
por: Rosenberg, Daniel, et al.
Publicado: (2021) -
Pentosan Polysulfate: A Novel Therapy for the Mucopolysaccharidoses
por: Schuchman, Edward H., et al.
Publicado: (2013) -
Visual Function in Pentosan Polysulfate Sodium Maculopathy
por: Lyons, Riley J., et al.
Publicado: (2020) -
Type 3 macular neovascularization in a patient with pentosan polysulfate maculopathy
por: Bousquet, Elodie, et al.
Publicado: (2022) -
Potential Anti-SARS-CoV-2 Activity of Pentosan Polysulfate and Mucopolysaccharide Polysulfate
por: Zhang, Fuming, et al.
Publicado: (2022)